Our mission is to become a transnational pharmaceutical company through the development and introduction of a wide portfolio of branded and generic products in key markets.
GENERICS
Lupin Pharmaceuticals, Inc. entered the U.S. generic pharmaceutical market in 2003 with the ANDA approval for cefuroxime axetil.
SPECIALTY
We are very pleased to be able to bring Suprax® an important anti-infective product in pediatric practice, back to the US market.
API
We are recognized as a leading manufacturer of cephalosporin API’s, with FDA approval to manufacture complex oral and injectable cephalosporins.
For Aerochamber Plus® information, go to the following website link:
http://www.Aerochambervhc.com
LUPIN
Lupin is amongst the world's largest manufacturers of products in its chosen therapeutic areas.
Lupin Announces U.S. FDA Approval of its First Oral Contraceptive
Lupin Announces Launch of Generic KEPPRA XR® Tablets
Lupin Announces Launch of Generic Version of Ponstel® Capsules
Lupin Receives Final Approval to Market Generic Ultram® ER
Lupin Launches Additional Strengths of Generic Lotrel® Capsules
Lupin Announces Launch of Generic Levaquin® Tablets for the US Market
Copyright © 2010, Lupin Pharmaceuticals, Inc., All Rights Reserved.
Created and Designed by
Gayatri Microsystems